Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 128

1.

IL1B polymorphisms modulate cystic fibrosis lung disease.

Levy H, Murphy A, Zou F, Gerard C, Klanderman B, Schuemann B, Lazarus R, García KC, Celedón JC, Drumm M, Dahmer M, Quasney M, Schneck K, Reske M, Knowles MR, Pier GB, Lange C, Weiss ST.

Pediatr Pulmonol. 2009 Jun;44(6):580-93. doi: 10.1002/ppul.21026.

2.

Genetic modifiers of lung disease in cystic fibrosis.

Drumm ML, Konstan MW, Schluchter MD, Handler A, Pace R, Zou F, Zariwala M, Fargo D, Xu A, Dunn JM, Darrah RJ, Dorfman R, Sandford AJ, Corey M, Zielenski J, Durie P, Goddard K, Yankaskas JR, Wright FA, Knowles MR; Gene Modifier Study Group.

N Engl J Med. 2005 Oct 6;353(14):1443-53.

3.

Analysis of DEFB1 regulatory SNPs in cystic fibrosis patients from North-Eastern Italy.

Segat L, Morgutti M, Athanasakis E, Trevisiol C, Amaddeo A, Poli F, Crovella S.

Int J Immunogenet. 2010 Jun;37(3):169-75. doi: 10.1111/j.1744-313X.2010.00907.x. Epub 2010 Feb 24.

PMID:
20193032
4.

CFTR genotype and clinical outcomes of adult patients carried as cystic fibrosis disease.

Bonadia LC, de Lima Marson FA, Ribeiro JD, Paschoal IA, Pereira MC, Ribeiro AF, Bertuzzo CS.

Gene. 2014 May 1;540(2):183-90. doi: 10.1016/j.gene.2014.02.040. Epub 2014 Feb 26.

PMID:
24583165
5.

Genetic variations in toll-like receptor pathway and lung function decline in Cystic fibrosis patients.

Haerynck F, Mahachie John JM, Van Steen K, Schelstraete P, Van daele S, Loeys B, Van Thielen M, De Canck I, Nuytinck L, De Baets F.

Hum Immunol. 2013 Dec;74(12):1649-55. doi: 10.1016/j.humimm.2013.08.282. Epub 2013 Aug 29.

PMID:
23994582
6.
7.

Association of MBL2, TGF-beta1 and CD14 gene polymorphisms with lung disease severity in cystic fibrosis.

Faria EJ, Faria IC, Ribeiro JD, Ribeiro AF, Hessel G, Bertuzzo CS.

J Bras Pneumol. 2009 Apr;35(4):334-42. English, Portuguese.

8.

Interaction between a novel TGFB1 haplotype and CFTR genotype is associated with improved lung function in cystic fibrosis.

Bremer LA, Blackman SM, Vanscoy LL, McDougal KE, Bowers A, Naughton KM, Cutler DJ, Cutting GR.

Hum Mol Genet. 2008 Jul 15;17(14):2228-37. doi: 10.1093/hmg/ddn123. Epub 2008 Apr 17.

9.

Cytokine gene polymorphisms and severity of CF lung disease.

de Vries L, Griffiths A, Armstrong D, Robinson PJ.

J Cyst Fibros. 2014 Dec;13(6):699-705. doi: 10.1016/j.jcf.2014.04.007. Epub 2014 May 19.

10.

Identification of SNPs in the cystic fibrosis interactome influencing pulmonary progression in cystic fibrosis.

Gisler FM, von Kanel T, Kraemer R, Schaller A, Gallati S.

Eur J Hum Genet. 2013 Apr;21(4):397-403. doi: 10.1038/ejhg.2012.181. Epub 2012 Aug 15.

11.

A polymorphism in the 5' UTR of the DEFB1 gene is associated with the lung phenotype in F508del homozygous Italian cystic fibrosis patients.

Crovella S, Segat L, Amato A, Athanasakis E, Bezzerri V, Braggion C, Casciaro R, Castaldo G, Colombo C, Covone AE, De Rose V, Gagliardini R, Lanzara C, Minicucci L, Morgutti M, Nicolis E, Pardo F, Quattrucci S, Raia V, Ravazzolo R, Seia M, Stanzial V, Termini L, Zazzeron L, Cabrini G, Gasparini P.

Clin Chem Lab Med. 2011 Jan;49(1):49-54. doi: 10.1515/CCLM.2011.023. Epub 2010 Nov 16.

PMID:
21077791
12.

Categories of deltaF508 homozygous cystic fibrosis twin and sibling pairs with distinct phenotypic characteristics.

Mekus F, Ballmann M, Bronsveld I, Bijman J, Veeze H, Tümmler B.

Twin Res. 2000 Dec;3(4):277-93.

PMID:
11463149
13.

Variants in the glutamate-cysteine-ligase gene are associated with cystic fibrosis lung disease.

McKone EF, Shao J, Frangolias DD, Keener CL, Shephard CA, Farin FM, Tonelli MR, Pare PD, Sandford AJ, Aitken ML, Kavanagh TJ.

Am J Respir Crit Care Med. 2006 Aug 15;174(4):415-9. Epub 2006 May 11.

14.

Polymorphisms in the glutathione pathway modulate cystic fibrosis severity: a cross-sectional study.

Marson FA, Bertuzzo CS, Ribeiro AF, Ribeiro JD.

BMC Med Genet. 2014 Mar 4;15:27. doi: 10.1186/1471-2350-15-27.

15.

CLC-2 single nucleotide polymorphisms (SNPs) as potential modifiers of cystic fibrosis disease severity.

Blaisdell CJ, Howard TD, Stern A, Bamford P, Bleecker ER, Stine OC.

BMC Med Genet. 2004 Oct 26;5:26.

16.

Fcgamma receptor IIA genotype and susceptibility to P. aeruginosa infection in patients with cystic fibrosis.

De Rose V, Arduino C, Cappello N, Piana R, Salmin P, Bardessono M, Goia M, Padoan R, Bignamini E, Costantini D, Pizzamiglio G, Bennato V, Colombo C, Giunta A, Piazza A.

Eur J Hum Genet. 2005 Jan;13(1):96-101.

17.

Polymorphisms in ADRB2 gene can modulate the response to bronchodilators and the severity of cystic fibrosis.

Marson FA, Bertuzzo CS, Ribeiro AF, Ribeiro JD.

BMC Pulm Med. 2012 Sep 5;12:50. doi: 10.1186/1471-2466-12-50.

18.

Association of tumour necrosis factor alpha variants with the CF pulmonary phenotype.

Yarden J, Radojkovic D, De Boeck K, Macek M Jr, Zemkova D, Vavrova V, Vlietinck R, Cassiman JJ, Cuppens H.

Thorax. 2005 Apr;60(4):320-5.

19.

Histo-blood group gene polymorphisms as potential genetic modifiers of infection and cystic fibrosis lung disease severity.

Taylor-Cousar JL, Zariwala MA, Burch LH, Pace RG, Drumm ML, Calloway H, Fan H, Weston BW, Wright FA, Knowles MR; Gene Modifier Study Group.

PLoS One. 2009;4(1):e4270. doi: 10.1371/journal.pone.0004270. Epub 2009 Jan 26.

20.

Comparison of radiographic and clinical characteristics of low-risk and high-risk cystic fibrosis genotypes.

Ferril GR, Nick JA, Getz AE, Barham HP, Saavedra MT, Taylor-Cousar JL, Nichols DP, Curran-Everett D, Kingdom TT, Ramakrishnan VR.

Int Forum Allergy Rhinol. 2014 Nov;4(11):915-20. doi: 10.1002/alr.21412. Epub 2014 Sep 15.

PMID:
25224556

Supplemental Content

Support Center